down arrow

Alembic Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
840.00
1.5 (0.18%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
6,228.63
5,652.62
5,305.79
5,393.13
4,605.75
3,934.68
3,130.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,228.63
5,652.62
5,305.79
5,393.13
4,605.75
3,934.68
3,130.81
Raw Material Cost
1,403.01
1,250.08
1,129.11
1,185.35
979.05
850.04
725.75
Purchase of Finished goods
454.91
380.09
360.50
265.92
270.93
234.93
201.87
(Increase) / Decrease In Stocks
-142.84
78.65
-43.19
-193.93
-210.59
-92.27
-42.06
Employee Cost
1,446.29
1,169.13
1,133.00
1,051.17
906.44
746.69
622.81
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
979.34
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
2,133.90
2,066.30
1,852.21
1,604.34
1,436.91
1,321.71
0.00
Total Expenditure (Excl Depreciation)
5,295.27
4,944.25
4,431.63
3,912.85
3,382.74
3,061.10
2,487.71
Operating Profit (PBDIT) excl Other Income
933.36
708.37
874.16
1,480.28
1,223.01
873.58
643.10
Other Income
28.31
2.74
50.46
87.29
4.94
9.38
7.03
Operating Profit (PBDIT)
961.67
711.11
924.62
1,567.57
1,227.95
882.96
650.13
Interest
56.19
50.17
17.73
16.02
27.16
18.41
3.40
Exceptional Items
0.00
0.00
0.00
0.00
-43.64
0.00
0.00
Gross Profit (PBDT)
905.48
660.94
906.89
1,551.55
1,157.15
864.55
646.73
Depreciation
272.67
275.43
286.78
183.47
157.32
115.23
105.46
Profit Before Tax
632.81
385.51
620.11
1,368.08
999.83
749.32
541.27
Tax
16.01
12.60
104.46
253.32
199.18
156.75
120.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
616.80
372.91
515.65
1,114.76
800.65
592.57
420.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
616.80
372.91
515.65
1,114.76
800.65
592.57
420.91
Share in Profit of Associates
-0.98
-30.92
5.28
31.74
0.05
-9.28
-8.09
Minority Interest
0.00
0.00
24.75
31.61
28.12
1.08
-0.19
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
615.82
341.99
545.68
1,178.11
828.82
584.37
412.63
Equity Capital
39.31
39.31
39.31
39.31
37.70
37.70
37.70
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
4,778.89
4,331.16
5,198.23
5,088.30
3,181.71
2,681.12
0.00
Earnings per share (EPS)
31.33
17.4
27.76
59.94
43.97
31.0
21.89
Diluted Earnings per share
30.78
17.4
27.76
60.81
43.97
31.0
21.89
Operating Profit Margin (Excl OI)
14.98%
12.53%
16.48%
27.45%
26.55%
22.2%
20.54%
Gross Profit Margin
14.54%
11.69%
17.09%
28.77%
25.12%
21.97%
20.66%
PAT Margin
9.89%
6.05%
9.72%
20.67%
17.38%
15.06%
13.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 10.19% vs 6.54% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 80.07% vs -37.33% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 31.76% vs -18.97% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 12.00% vs 182.97% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Alembic Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
6,228.63
10,334.77
-4,106.14
-39.73%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,228.63
10,334.77
-4,106.14
-39.73%
Raw Material Cost
1,403.01
1,853.52
-450.51
-24.31%
Purchase of Finished goods
454.91
1,409.85
-954.94
-67.73%
(Increase) / Decrease In Stocks
-142.84
-53.67
-89.17
-166.14%
Employee Cost
1,446.29
2,274.73
-828.44
-36.42%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2,133.90
2,315.28
-181.38
-7.83%
Total Expenditure (Excl Depreciation)
5,295.27
7,799.71
-2,504.44
-32.11%
Operating Profit (PBDIT) excl Other Income
933.36
2,535.06
-1,601.70
-63.18%
Other Income
28.31
280.86
-252.55
-89.92%
Operating Profit (PBDIT)
961.67
2,815.92
-1,854.25
-65.85%
Interest
56.19
33.53
22.66
67.58%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
905.48
2,782.39
-1,876.91
-67.46%
Depreciation
272.67
398.25
-125.58
-31.53%
Profit Before Tax
632.81
2,384.14
-1,751.33
-73.46%
Tax
16.01
457.58
-441.57
-96.50%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
616.80
1,926.56
-1,309.76
-67.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
616.80
1,926.56
-1,309.76
-67.98%
Share in Profit of Associates
-0.98
15.21
-16.19
-106.44%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
615.82
1,912.90
-1,297.08
-67.81%
Equity Capital
39.31
40.06
-0.75
-1.87%
Face Value
2.00
1.00
0.00
Reserves
4,778.89
9,323.03
-4,544.14
-48.74%
Earnings per share (EPS)
31.33
47.75
-16.42
-34.39%
Diluted Earnings per share
30.78
47.68
-16.90
-35.44%
Operating Profit Margin (Excl OI)
14.98%
24.53%
0.00
-9.55%
Gross Profit Margin
14.54%
26.92%
0.00
-12.38%
PAT Margin
9.89%
18.79%
0.00
-8.90%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 6,228.63 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 10.19% vs 6.54% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 615.82 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 80.07% vs -37.33% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 933.36 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 31.76% vs -18.97% in Mar 2023

Annual - Interest
Interest 56.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 12.00% vs 182.97% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.98%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023